SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-082189
Filing Date
2021-03-16
Accepted
2021-03-16 08:11:32
Documents
15
Period of Report
2021-03-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d130909d8k.htm   iXBRL 8-K 25087
2 EX-99.1 d130909dex991.htm EX-99.1 87726
7 GRAPHIC g130909g85s48.jpg GRAPHIC 5475
  Complete submission text file 0001193125-21-082189.txt   290340

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cprx-20210315.xsd EX-101.SCH 3797
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20210315_def.xml EX-101.DEF 13772
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20210315_lab.xml EX-101.LAB 22756
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20210315_pre.xml EX-101.PRE 14768
8 EXTRACTED XBRL INSTANCE DOCUMENT d130909d8k_htm.xml XML 4782
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 21743695
SIC: 2834 Pharmaceutical Preparations